|
1
|
Wittström E: Central retinal vein
occlusion in younger Swedish adults: Case reports and review of the
literature. Open Ophthalmol J. 11:89–102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yau JW, Lee P, Wong TY, Best J and Jenkins
A: Retinal vein occlusion: An approach to diagnosis, systemic risk
factors and management. Intern Med J. 38:904–910. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nroev VV: Modern aspects of diabetic
retinopathy and diabetic macularoedema treatment. Vestn Ross Akad
Med Nauk. 1:61–65. 2012.
|
|
4
|
Kolar P: Risk factors for central and
branch retinal vein occlusion: A meta-analysis of published
clinical data. J Ophthalmol. 2014:7247802014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kuo JZ, Lai CC, Ong FS, Shih CP, Yeung L,
Chen TL, Chen KJ and Wu WC: Central retinal vein occlusion in a
young Chinese population: Risk factors and associated morbidity and
mortality. Retina. 30:479–484. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Priluck IA, Robertson DM and Hollenhorst
RW: Long-term follow-up of occlusion of the central retinal vein in
young adults. Am J Ophthalmol. 90:190–202. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spaide RF, Chang LK, Klancnik JM, Yannuzzi
LA, Sorenson J, Slakter JS, Freund KB and Klein R: Prospective
study of intravitreal ranibizumab as a treatment for decreased
visual acuity secondary to central retinal vein occlusion. Am J
Ophthalmol. 147:298–306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Keshav BR, Zacharia G, Bhat VK, Joseph MK
and Ideculla T: Laser therapy in diabetic macular edema. Oman Med
J. 23:28–31. 2008.
|
|
9
|
Ashraf M, Souka AA and Singh RP: Central
retinal vein occlusion: Modifying current treatment protocols. Eye
(Lond). 30:505–514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ip MS, Scott IU, VanVeldhuisen PC, Oden
NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK and
Gonzalez VH: SCORE Study Research Group: A randomized trial
comparing the efficacy and safety of intravitreal triamcinolone
with observation to treat vision loss associated with macular edema
secondary to central retinal vein occlusion: The Standard Care vs
Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5.
Arch Ophthalmol. 127:1101–1114. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haller JA, Bandello F, Belfort R Jr,
Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J,
Li XY, et al: Ozurdex GENEVA Study Group: Dexamethasone
intravitreal implant in patients with macular edema related to
branch or central retinal vein occlusion twelve-month study
results. Ophthalmology. 118:2453–2460. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sellam A, Glacet-Bernard A, Coscas F and
Souied EH: Abnormal retinal artery perfusion and optical coherence
tomography angiography. J Fr Ophtalmol. 40:353–362. 2017.(In
French). View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vogl WD, Waldstein SM, Gerendas BS,
Schmidt-Erfurth U and Langs G: Predicting macular edema recurrence
from spatio-temporal signatures in optical coherence tomography
images. IEEE Trans Med Imaging. 36:1773–1783. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Puche N, Glacet A, Mimoun G, Zourdani A,
Coscas G and Soubrane G: Intravitreal ranibizumab for macular
oedema secondary to retinal vein occlusion: A retrospective study
of 34 eyes. Acta Ophthalmol. 90:357–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mete A, Saygili O, Mete A, Gungor K,
Bayram M and Bekir N: Does ranibizumab (Lucentis®)
change retrobulbar blood flow in patients with neovascular
age-related macular degeneration? Ophthalmic Res. 47:141–145. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lucatto LFA, Magalhães-Junior O, Prazeres
JMB, Ferreira AM, Oliveira RA, Moraes NS, Hirai FE and Maia M:
Incidence of anterior segment neovascularization during
intravitreal treatment for macular edema secondary to central
retinal vein occlusion. Arq Bras Oftalmol. 80:97–103. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ghasemi Falavarjani K, Iafe NA, Hubschman
JP, Tsui I, Sadda SR and Sarraf D: Optical coherence tomography
angiography analysis of the foveal avascular zone and macular
vessel density after anti-VEGF therapy in eyes with diabetic
macular edema and retinal vein occlusion. Invest Ophthalmol Vis
Sci. 58:30–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bitirgen G, Belviranli S, Malik RA,
Kerimoglu H and Ozkagnici A: Effects of panretinal laser
photocoagulation on the corneal nerve plexus and retinal nerve
fiber layer in retinal vein occlusion. Eur J Ophthalmol.
27:591–595. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pikkel YY, Sharabi-Nov A, Beiran I and
Pikkel J: Comparison of anti-vascular endothelial growth factors,
laser treatments and a combination of the both for treatment of
central retinal vein occlusion. Int J Ophthalmol. 9:431–433.
2016.PubMed/NCBI
|
|
20
|
Patel A, Nguyen C and Lu S: Central
retinal vein occlusion: A review of current evidence-based
treatment options. Middle East Afr J Ophthalmol. 23:44–48. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yeh S, Kim SJ, Ho AC, Schoenberger SD,
Bakri SJ, Ehlers JP and Thorne JE: Therapies for macular edema
associated with central retinal vein occlusion: A report by the
American Academy of Ophthalmology. Ophthalmology. 122:769–778.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang L, Ke Y, Wang W, Shi X, Hei K and Li
X: The efficacy of conbercept or ranibizumab intravitreal injection
combined with laser therapy for Coats' disease. Graefes Arch Clin
Exp Ophthalmol. 256:1339–1346. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tadayoni R, Waldstein SM, Boscia F,
Gerding H, Gekkieva M, Barnes E, Das Gupta A, Wenzel A and Pearce
I: BRIGHTER Study Group: Sustained benefits of ranibizumab with or
without laser in branch retinal vein occlusion: 24-month results of
the BRIGHTER Study. Ophthalmology. 124:1778–1787. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bertelmann T, Frank HU, Fuchs HA and
Feltgen N: Branch retinal vein occlusion, macular ischemia, and
intravitreal anti-VEGF therapy. Case Rep Ophthalmol. 8:271–278.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ehlers JP, Kim SJ, Yeh S, Thorne JE,
Mruthyunjaya P, Schoenberger SD and Bakri SJ: Therapies for macular
edema associated with branch retinal vein occlusion: A report by
the american academy of ophthalmology. Ophthalmology.
124:1412–1423. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sakanishi Y, Usui-Ouchi A, Tamaki K,
Mashimo K, Ito R and Ebihara N: Short-term outcomes in patients
with branch retinal vein occlusion who received intravitreal
aflibercept with or without intravitreal ranibizumab. Clin
Ophthalmol. 11:829–834. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chung CY and Li KKW: Optical coherence
tomography angiography wide-field montage in branch retinal vein
occlusion before and after anti-vascular endothelial-derived growth
factor injection. Int Ophthalmol. 38:1305–1307. 2018. View Article : Google Scholar : PubMed/NCBI
|
